MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)
source: myfinsight.com
Net loss available
to common...
-$14,610,000
Net gain
-$12,845,000
(-99.58%↓ Y/Y)
Warrant deemed dividend
$1,765,000
Gain from change in
fair value of warrant...
-$10,770,000
(-18.95%↓ Y/Y)
Other income, net
$76,000
(744.44%↑ Y/Y)
Interest income, net
$34,000
(13.33%↑ Y/Y)
Gain on issuance of
warrant liabilities
-$15,158,000
(-94.38%↓ Y/Y)
Loss from operations
-$7,874,000
(-32.49%↓ Y/Y)
Transaction costs allocated
to warrant...
$693,000
(-61.24%↓ Y/Y)
Total operating
expenses
$7,874,000
(32.49%↑ Y/Y)
Research and development
$5,378,000
(56.56%↑ Y/Y)
General and
administrative
$2,488,000
(0.44%↑ Y/Y)
Depreciation and
amortization
$8,000
(-74.19%↓ Y/Y)
Back